Epigenomics AG: Announcement of the Convening of the General Meeting in Berlin on 30.05.2018 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution

11:04 EDT 20 Apr 2018 | EQS Group

DGAP-News: Epigenomics AG / Announcement of the Convening of the General Meeting

20.04.2018 / 15:04
Announcement according to article 121 AktG (German Stock Companies Act), transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Epigenomics AG announces the convening of the General Meeting. Please find
the full text of the announcement here:

English: http://dgap.hv.eqs.com/180412038394/en/Epigenomics oHV 2018 - Einberufung (Engl.) Clean.pdf

20.04.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Epigenomics AG
Geneststr. 5
10829 Berlin
Germany
Phone: +49 30 243450
Fax: +49 30 24345555
E-mail: ir@epigenomics.com
Internet: http://www.epigenomics.com
ISIN: DE000A11QW50
WKN: A11QW5
Listed: Foreign Exchange(s) Regulierter Markt in Frankfurt (Prime Standard), , Freiverkehr in Berlin, Düsseldorf, München, Stuttgart,, Tradegate Exchange

End of News DGAP News Service
show this

More From BioPortfolio on "Epigenomics AG: Announcement of the Convening of the General Meeting in Berlin on 30.05.2018 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution"